Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model

Dilan Khalili, Christina Kalcher, Stefan Baumgartner, Ulrich Theopold

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Fibrotic lesions accompany several pathological conditions, including tumors. We show that expression of a dominant-active form of the Ras oncogene in Drosophila salivary glands (SGs) leads to redistribution of components of the basement membrane (BM) and fibrotic lesions. Similar to several types of mammalian fibrosis, the disturbed BM attracts clot components, including insect transglutaminase and phenoloxidase. SG epithelial cells show reduced apicobasal polarity accompanied by a loss of secretory activity. Both the fibrotic lesions and the reduced cell polarity are alleviated by ectopic expression of the antimicrobial peptide drosomycin (Drs), which also restores the secretory activity of the SGs. In addition to extracellular matrix components, both Drs and F-actin localize to fibrotic lesions.

    Original languageEnglish
    Pages (from-to)376-390
    JournalJournal of Innate Immunity
    Volume13
    Issue number6
    Early online date2021
    DOIs
    Publication statusPublished - 2021

    Subject classification (UKÄ)

    • Biochemistry and Molecular Biology
    • Cell and Molecular Biology

    Free keywords

    • Antimicrobial peptides
    • Extracellular matrix
    • Fibrosis
    • Innate immunity
    • Insect immunity

    Fingerprint

    Dive into the research topics of 'Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model'. Together they form a unique fingerprint.

    Cite this